Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.


Journal

Small (Weinheim an der Bergstrasse, Germany)
ISSN: 1613-6829
Titre abrégé: Small
Pays: Germany
ID NLM: 101235338

Informations de publication

Date de publication:
03 2023
Historique:
revised: 08 12 2022
received: 28 09 2022
pubmed: 2 1 2023
medline: 25 3 2023
entrez: 1 1 2023
Statut: ppublish

Résumé

Improving the tumor reoxygenation to sensitize the tumor to radiation therapy is a cornerstone in radiation oncology. Here, the pre-clinical development of a clinically transferable liposomal formulation encapsulating trans sodium crocetinate (NP TSC) is reported to improve oxygen diffusion through the tumor environment. Early pharmacokinetic analysis of the clinical trial of this molecule performed on 37 patients orient to define the optimal fixed dosage to use in a triple-negative breast cancer model to validate the therapeutic combination of radiation therapy and NP TSC. Notably, it is reported that this formulation is non-toxic in both humans and mice at the defined fixed concentration, provides a normalization of the tumor vasculature within 72 h window after systemic injection, leads to a transient increase (50% improvement) in the tumor oxygenation, and significantly improves the efficacy of both mono-fractionated and fractionated radiation therapy treatment. Together, these findings support the introduction of a first-in-class therapeutic construct capable of tumor-specific reoxygenation without associated toxicities.

Identifiants

pubmed: 36587987
doi: 10.1002/smll.202205961
doi:

Substances chimiques

trans-sodium crocetinate 0
Carotenoids 36-88-4
Vitamin A 11103-57-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2205961

Informations de copyright

© 2022 The Authors. Small published by Wiley-VCH GmbH.

Références

J. M. Brown, W. R. Wilson, Nat. Rev. Cancer 2004, 4, 437.
G. L. Semenza, Cancer Cell 2004, 5, 405.
W. R. Wilson, M. P. Hay, Nat. Rev. Cancer 2011, 11, 393.
L. H. Gray, A. D. Conger, M. Ebert, S. Hornsey, O. C. A. Scott, Br. J. Radiol. 1953, 26, 638.
R. K. Jain, J. Clin. Oncol. 2013, 31, 2205.
R. K. Jain, Science 2005, 307, 58.
M. A. Schneider, M. Linecker, R. Fritsch, U. J. Muehlematter, D. Stocker, B. Pestalozzi, P. Samaras, A. Jetter, P. Kron, H. Petrowsky, C. Nicolau, J.-M. Lehn, B. Humar, R. Graf, P.-A. Clavien, P. Limani, Nat. Commun. 2021, 12, 3807.
P. M. Tibbles, J. S. Edelsberg, N. Engl. J. Med. 1996, 334, 1642.
L. T. Goodnough, M. E. Brecher, M. H. Kanter, J. P. AuBuchon, N. Engl. J. Med. 1999, 340, 438.
J. A. Glaspy, Annu. Rev. Med. 2009, 60, 181.
Z. Tao, P. P. Ghoroghchian, Trends Biotechnol. 2014, 32, 466.
Y. Shi, R. van der Meel, X. Chen, T. Lammers, Theranostics 2020, 10, 7921.
Y. Matsumura, H. Maeda, Cancer Res. 1986, 46, 6387.
S. Rey, L. Schito, M. Koritzinsky, B. G. Wouters, Adv Drug Deliv Rev 2017, 109, 45.
J. R. Mackey, R. S. Kerbel, K. A. Gelmon, D. M. McLeod, S. K. Chia, D. Rayson, S. Verma, L. L. Collins, A. H. G. Paterson, A. Robidoux, K. I. Pritchard, Cancer Treat. Rev. 2012, 38, 673.
R. Bell, J. Brown, M. Parmar, M. Toi, T. Suter, G. G. Steger, X. Pivot, J. Mackey, C. Jackisch, R. Dent, P. Hall, N. Xu, L. Morales, L. Provencher, R. Hegg, L. Vanlemmens, A. Kirsch, A. Schneeweiss, N. Masuda, F. Overkamp, D. Cameron, Ann. Oncol. 2017, 28, 754.
V. P. Chauhan, J. D. Martin, H. Liu, D. A. Lacorre, S. R. Jain, S. V. Kozin, T. Stylianopoulos, A. S. Mousa, X. Han, P. Adstamongkonkul, Z. Popovic, P. Huang, M. G. Bawendi, Y. Boucher, R. K. Jain, Nat. Commun. 2013, 4, 2516.
P.-M. Mertes, O. Collange, P. Coliat, M. Banerjee, M.-C. Diringer, A. Roche, X. Delabranche, V. Chaban, M. Voegelin, A. Bernard, V. Sartori, N. Laurent, M. Velten, N. Dhindsa, J. Defuria, G. Kim, Z. H. Xu, M. Theodorou, Z. R. Huang, K. Khalifa, B. Geng, C. Niyikiza, V. Moyo, P. Gizzi, P. Villa, A. Detappe, X. Pivot, J. Controlled Release 2021, 336, 252.
A. K. Stennett, G. L. Dempsey, J. L. Gainer, J. Phys. Chem. B 2006, 110, 18078.
J. Sheehan, J. Sherman, C. Cifarelli, J. Jagannathan, K. Dassoulas, C. Olson, J. Rainey, S. Han, J. Neurosurg. 2009, 111, 226.
J. Sheehan, A. Ionescu, N. Pouratian, D. K. Hamilton, D. Schlesinger, R. J. OskouianJr., C. Sansur, J. Neurosurg. 2008, 108, 972.
H. M. Shah, A. S. Jain, S. V. Joshi, P. S. Kharkar, Drug Dev. Res. 2021, 82, 883.
Z.-L. Guo, M.-X. Li, X.-L. Li, P. Wang, W.-G. Wang, W.-Z. Du, Z.-Q. Yang, S.-F. Chen, D. Wu, X.-Y. Tian, Front. Pharmacol. 2021, 12, 745683.
G. M. Holloway, J. L. Gainer, J. Appl. Physiol. 1988, 65, 683.
P.-M. Mertes, X. Delabranche, P. Coliat, A. Roche, O. Collange, M. Voegelin, A. Bernard, N. Dhindsa, Z. H. Xu, B. Geng, C. Niyikiza, V. Moyo, C. Bourban, P. Villa, A. Detappe, X. Pivot, medRxiv 2022, 2022.09.07.22279668.
V. Mittelheisser, P. Coliat, E. Moeglin, L. Goepp, J. G. Goetz, L. J. Charbonniere, X. Pivot, A. Detappe, Adv. Mater. 2022, 34, 2110305.
S. Wilhelm, A. J. Tavares, Q. Dai, S. Ohta, J. Audet, H. F. Dvorak, W. C. W. Chan, Nat. Rev. Mater. 2016, 1, 16014.
S. Sindhwani, A. M. Syed, J. Ngai, B. R. Kingston, L. Maiorino, J. Rothschild, P. MacMillan, Y. Zhang, N. U. Rajesh, T. Hoang, J. L. Y. Wu, S. Wilhelm, A. Zilman, S. Gadde, A. Sulaiman, B. Ouyang, Z. Lin, L. Wang, M. Egeblad, W. C. W. Chan, Nat. Mater. 2020, 19, 566.
S. A. Smith, L. I. Selby, A. P. R. Johnston, G. K. Such, Bioconjug Chem 2019, 30, 263.

Auteurs

Marie-Charlotte Diringer (MC)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Pierre Coliat (P)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Clélia Mathieu (C)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Nina Laurent (N)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Carole Mura (C)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Mainak Banerjee (M)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Chen Zhu (C)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Anna Grabowska (A)

Ex Vivo Cancer Pharmacology Centre, Biodiscovery Institute, Translational Medical Sciences, School of Medicine, University of Nottingham, UK.

Alison Ritchie (A)

Ex Vivo Cancer Pharmacology Centre, Biodiscovery Institute, Translational Medical Sciences, School of Medicine, University of Nottingham, UK.

Philip Clarke (P)

Ex Vivo Cancer Pharmacology Centre, Biodiscovery Institute, Translational Medical Sciences, School of Medicine, University of Nottingham, UK.

Alexandre Bernard (A)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Claire Vit (C)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Hélène Burckel (H)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Georges Noel (G)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Peter Harvey (P)

Sir Peter Mansfield Imaging Centre, School of Medicine and School of Chemistry, University of Nottingham, UK.

Xavier Pivot (X)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.

Alexandre Detappe (A)

Institut de Cancérologie Strasbourg Europe, Strasbourg, France.
Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH